Novartis India Limited at its board meeting held on May 9, 2025, has recommended the final dividend of INR 25 per equity share (of the face value of INR 5 each) for the financial year ended as on March 31, 2025 subject to the approval of the shareholders in the upcoming Annual General Meeting of the Company scheduled to be held on July 31, 2025. In continuation to the above and pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed July 23, 2025, as the Record Date for determining entitlement of Members to final dividend for the financial year ended March 31, 2025. If the final dividend as recommended by the Board of Directors is approved at the AGM, such dividend will be paid /dispatched, subject to deduction of tax at source after the AGM.